DR. MIKHAIL DOUBROVIN M.D., PH.D.
NPI 1801054119
Nuclear Medicine in New York, NY

Active since May 23, 2008PECOS EnrolledAccepts Medicare Assignment
100/100
CMS Quality Rating
630 W 168TH ST DEPT OF, NEW YORK, NY 10032(212) 305-1948(212) 305-5777 Get Directions Write a Review

NPPES record last updated: March 23, 2020. Verified against the NPPES registry weekly; last sync: August 02, 2026.

About Dr. Mikhail Doubrovin M.d., Ph.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. MIKHAIL DOUBROVIN M.D., PH.D. (NPI 1801054119) is an individual nuclear medicine provider in New York, New York, licensed in New York (250091) and active in the NPI registry since May 2008. He is enrolled in Medicare PECOS, is affiliated with New York-presbyterian Hospital, and is a graduate of Other (1994).

NPPES Registry Identity

NPI1801054119
Entity TypeIndividualMale
Primary Taxonomy207U00000X
Provider Legal NameDR. MIKHAIL DOUBROVINCredential: M.D., PH.D.
Location Address630 W 168TH ST DEPT OFNew York, NY 10032-3725
Mailing Address630 W 168th StNew York, NY 10032-3725 · (212) 305-1948 · Fax (212) 305-5777
Fax(212) 305-5777
Sole ProprietorYes
Medical School CMSOtherGraduated 1994
Enumeration DateMay 23, 2008
Last NPPES UpdateMarch 23, 2020
NPPES CertifiedMarch 23, 2020
NPI 1801054119 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 4

Primary SpecialtyNuclear MedicineAllopathic & Osteopathic Physicians
Taxonomy Code207U00000X
License Licensed in NY · 250091
Definition
A nuclear medicine specialist employs the properties of radioactive atoms and molecules in the diagnosis and treatment of disease and in research. Radiation detection and imaging instrument systems are used to detect disease as it changes the function and metabolism of normal cells, tissues and organs. A wide variety of diseases can be found in this way, usually before the structure of the organ involved by the disease can be seen to be abnormal by any other techniques. Early detection of coronary artery disease (including acute heart attack), early cancer detection and evaluation of the effect of tumor treatment, diagnosis of infection and inflammation anywhere in the body and early detection of blood clot in the lungs are all possible with these techniques. Unique forms of radioactive molecules can attack and kill cancer cells (e.g., lymphoma, thyroid cancer) or can relieve the severe pain of cancer that has spread to bone
Also ListedNuclear Medicine · Nuclear Imaging & TherapyTaxonomy 207UN0902X · License 250091 (NY)
Also ListedNuclear Medicine · In Vivo & In Vitro Nuclear MedicineTaxonomy 207UN0903X · License 250091 (NY)
Also ListedPediatricsTaxonomy 208000000X · License 250091 (NY)
630 W 168TH ST DEPT OF, New York, NY 10032

Other Identifiers 1

MedicaidQ013763NY

Group Practice 1

Group TaxonomyThis provider is a business group of one or more individual practitioners, who practice with different areas of specialization.193200000X MULTI-SPECIALTY GROUP

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Dr. Mikhail Doubrovin M.d., Ph.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID9537487228
PECOS Enrollment IDI20180530000630
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 21

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries A9552
Fluorodeoxyglucose F-18 FDG is a radioactive drug used in PET scans. It helps doctors see how your tissues and organs are functioning. The drug is given in a specific dose, up to 45 millicuries, depending on your body size and the type of scan.
433 services365 patients
Nuclear medicine study from skull base to mid-thigh with ct scan 78815
A nuclear medicine study from skull base to mid-thigh with a CT scan involves using a small amount of radioactive material and CT imaging to examine body tissues and organs. This helps detect any abnormalities by providing detailed images of the body's internal structure.
404 services344 patients
Nuclear medicine study from skull base to mid-thigh with ct scan 78815
A nuclear medicine study from skull base to mid-thigh with a CT scan involves using a small amount of radioactive material and CT imaging to examine body tissues and organs. This helps detect any abnormalities by providing detailed images of the body's internal structure.
394 services320 patients
Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie A9596
Gallium Ga-68 Gozetotide (Illuccix) is a diagnostic procedure using a radioactive tracer. It helps visualize certain types of tumors in your body by injecting a small amount of radioactive material. This is safe and aids doctors in accurate diagnosis and treatment planning.
243 services43 patients
Nuclear medicine study limited area with ct scan 78814
A nuclear medicine study with a limited area CT scan is a diagnostic procedure. A small amount of radioactive substance is injected into your body, which helps create detailed images of a specific area. The CT scan further enhances these images, providing clearer, more precise results.
171 services171 patients
Nuclear medicine study of bone and/or joint whole body 78306
A nuclear medicine study of bone and/or joint whole body involves injecting a small amount of radioactive material into your body. This material travels to your bones and emits energy. A special camera captures this energy, creating images of your bones to help identify any abnormalities.
133 services118 patients

Hospital Affiliations CMS Care Compare 2

Hospitals where this provider delivers care, identified from recent Medicare claims and place-of-service records.

New York-Presbyterian Hospital

Acute Care Hospitals · New York, NY
5/5 CMS rating
OwnershipVoluntary non-profit - Private
CMS Certification Number330101
Location525 East 68th StreetNew York, NY 10065 · New York County
Emergency services Birthing friendly

Hudson Valley Hospital Center

Acute Care Hospitals · Cortlandt Manor, NY
3/5 CMS rating
OwnershipVoluntary non-profit - Private
CMS Certification Number330267
Location1980 Crompond RoadCortlandt Manor, NY 10567 · Westchester County
Emergency services Birthing friendly

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 10032 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$150.24 typical visit price
range $65.69 – $198.19
Typical copayment $37.56 (range $16.42 – $49.54)
Most-billed visit code 99204
Established Patient
$114.88 typical visit price
range $21.20 – $160.66
Typical copayment $28.72 (range $5.30 – $40.16)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

100/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored through an Alternative Payment Model
Quality86.8
Promoting Interoperability100
Improvement Activities40

Reported Quality Measures

Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy
Percentage of final reports for all patients, regardless of age, undergoing bone scintigraphy that include physician documentation of correlation with existing relevant imaging studies (e.g., x-ray, MRI, CT, etc.) that were performed
100%21 patients
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Mikhail Doubrovin's NPI number?

The NPI number for Mikhail Doubrovin is 1801054119. It was assigned to this individual provider in the NPPES registry on May 23, 2008.

Where is Mikhail Doubrovin located?

Mikhail Doubrovin practices at 630 W 168th St Dept Of, New York, NY 10032. The listed phone number is (212) 305-1948.

What is Mikhail Doubrovin's specialty?

The primary specialty registered for this NPI is Nuclear Medicine with taxonomy code 207U00000X.

Is Mikhail Doubrovin enrolled in Medicare?

Yes. Mikhail Doubrovin is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

Is Mikhail Doubrovin affiliated with any hospitals?

According to CMS data, Mikhail Doubrovin is affiliated with New York-Presbyterian Hospital and Hudson Valley Hospital Center.

When was this NPI record last updated?

The NPPES record for Mikhail Doubrovin was last updated on March 23, 2020. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 6 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.